Trials in New York, New York
Here are the top 10 medical studies for breast cancer in New York, New York
Popular Filters
Phase 3 Trials
PI3K/mTOR Inhibitor
Gedatolisib + Fulvestrant +/- Palbociclib for Advanced Breast Cancer
Recruiting2 awardsPhase 3
White Plains, New York
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Selective Estrogen Receptor Downregulator (SERD)
Imlunestrant for Early Breast Cancer
Recruiting2 awardsPhase 3
New York, New York
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Antibody-drug conjugate
Dato-DXd +/− Durvalumab for Breast Cancer
Recruiting2 awardsPhase 3
Ridgewood, New Jersey
This trial is testing a new treatment for patients with a specific type of breast cancer who still have cancer after surgery and initial treatments. The treatment uses a drug called Dato-DXd, which targets and kills cancer cells, and may also include durvalumab, which helps the immune system fight cancer. The goal is to see if this new treatment works better than current options.
Trials With No Placebo
Monoclonal Antibodies
ORM-5029 for HER2-Positive Breast Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug called ORM-5029 in patients with advanced cancers that have the HER2 protein. The drug aims to find and attack these specific cancer cells. ORM-5029 is being tested for its ability to target HER2-positive cancer cells, a strategy previously explored with other drugs.
PI3K/mTOR Inhibitor
Gedatolisib + Fulvestrant +/- Palbociclib for Advanced Breast Cancer
Recruiting2 awardsPhase 3
White Plains, New York
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Behavioral Intervention
Adherence Intervention for Breast Cancer Treatment Compliance
Recruiting1 award
New York, New York
This trial is testing whether or not a multi-component intervention can help people with early-stage breast cancer who are also taking cardiovascular disease medication to stick to their endocrine therapy.
CAR T-cell Therapy
TCR-T Cell Therapy for Cancer
Recruiting1 awardPhase 1
New Brunswick, New Jersey
This trial tests a new treatment using modified immune cells to target specific cancers. It focuses on patients with certain metastatic cancers that produce an abnormal protein. The treatment aims to use the body's own enhanced immune system to fight cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.